Skip to main content
Top
Published in: Clinical Rheumatology 1/2016

01-01-2016 | Original Article

Deoxyribonuclease I gene polymorphism and susceptibility to systemic lupus erythematosus

Authors: Milad Mohammadoo-Khorasani, Mahsa Musavi, Mahdieh Mousavi, Maryam Moossavi, Maryam Khoddamian, Mahnaz Sandoughi, Zahra Zakeri

Published in: Clinical Rheumatology | Issue 1/2016

Login to get access

Abstract

The DNASE1 gene is regarded as one of the susceptible genes for systemic lupus erythematosus (SLE). Recent studies have detected the presence of a variable number of tandem repeat (VNTR) polymorphisms at intron 4 in this gene. The current study aimed to investigate the influence of current polymorphism on SLE susceptibility in a sample of the Iranian population. The study included 163 patients and 180 unrelated healthy controls. The VNTR polymorphisms in the DNASE1 gene were determined by polymerase chain reaction (PCR). The genotypic frequency investigation indicated that 3/6 genotype frequency in patients affected with SLE was more than healthy controls (P = 0.004). Moreover, 3/4 and 4/6 genotype frequencies in healthy cohort were further in comparison with patient cohort (P = 0.0001). Findings of the present study manifested that 3/6 genotype in patients affected with SLE was significantly more than healthy controls, thus it can be regarded as a risk factor, while 3/4 and 4/6 genotypes were significantly higher in healthy controls which can be considered as a protective factor.
Literature
2.
go back to reference Magnusson V, Nakken B, Bolstad A, Alarcón‐Riquelme M (2001) Cytokine polymorphisms in systemic lupus erythematosus and Sjögren’s syndrome. Scand J Immunol 54:55–61PubMedCrossRef Magnusson V, Nakken B, Bolstad A, Alarcón‐Riquelme M (2001) Cytokine polymorphisms in systemic lupus erythematosus and Sjögren’s syndrome. Scand J Immunol 54:55–61PubMedCrossRef
3.
go back to reference Chai HC, Phipps ME, Chua KH (2012) Genetic risk factors of systemic lupus erythematosus in the Malaysian population: a minireview. Clin Dev Immunol 2012:963730PubMedPubMedCentralCrossRef Chai HC, Phipps ME, Chua KH (2012) Genetic risk factors of systemic lupus erythematosus in the Malaysian population: a minireview. Clin Dev Immunol 2012:963730PubMedPubMedCentralCrossRef
4.
go back to reference Lau CS, Yin G, Mok MY (2006) Ethnic and geographical differences in systemic lupus erythematosus: an overview. Lupus 15:715–719PubMedCrossRef Lau CS, Yin G, Mok MY (2006) Ethnic and geographical differences in systemic lupus erythematosus: an overview. Lupus 15:715–719PubMedCrossRef
5.
go back to reference Helmick CG, Felson DT, Lawrence RC, Gabriel S, Hirsch R et al (2008) Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum 58:15–25PubMedCrossRef Helmick CG, Felson DT, Lawrence RC, Gabriel S, Hirsch R et al (2008) Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum 58:15–25PubMedCrossRef
6.
go back to reference Lindqvist A, Alarcón-Riquelme ME (1999) The genetics of systemic lupus erythematosus. Scand J Immunol 50:562–571PubMedCrossRef Lindqvist A, Alarcón-Riquelme ME (1999) The genetics of systemic lupus erythematosus. Scand J Immunol 50:562–571PubMedCrossRef
7.
go back to reference Sallai K, Nagy E, Derfalvy B, Muzes G, Gergely P (2005) Antinucleosome antibodies and decreased deoxyribonuclease activity in sera of patients with systemic lupus erythematosus. Clin Diagn Lab Immunol 12:56–59PubMedPubMedCentral Sallai K, Nagy E, Derfalvy B, Muzes G, Gergely P (2005) Antinucleosome antibodies and decreased deoxyribonuclease activity in sera of patients with systemic lupus erythematosus. Clin Diagn Lab Immunol 12:56–59PubMedPubMedCentral
8.
go back to reference Yasuda T, Awazu S, Sato W, Iida R, Tanaka Y et al (1990) Human genetically polymorphic deoxyribonuclease: purification, characterization, and multiplicity of urine deoxyribonuclease I. J Biochem 108:393–398PubMed Yasuda T, Awazu S, Sato W, Iida R, Tanaka Y et al (1990) Human genetically polymorphic deoxyribonuclease: purification, characterization, and multiplicity of urine deoxyribonuclease I. J Biochem 108:393–398PubMed
9.
go back to reference Mannherz HG, Peitsch MC, Zanotti S, Paddenberg R, Polzar B (1995) A new function for an old enzyme: the role of DNase I in apoptosis. Curr Top Microbiol Immunol 198:161–174PubMed Mannherz HG, Peitsch MC, Zanotti S, Paddenberg R, Polzar B (1995) A new function for an old enzyme: the role of DNase I in apoptosis. Curr Top Microbiol Immunol 198:161–174PubMed
10.
go back to reference Chitrabamrung S, Rubin RL, Tan EM (1981) Serum deoxyribonuclease I and clinical activity in systemic lupus erythematosus. Rheumatol Int 1:55–60PubMedCrossRef Chitrabamrung S, Rubin RL, Tan EM (1981) Serum deoxyribonuclease I and clinical activity in systemic lupus erythematosus. Rheumatol Int 1:55–60PubMedCrossRef
11.
go back to reference Napirei M, Karsunky H, Zevnik B, Stephan H, Mannherz HG et al (2000) Features of systemic lupus erythematosus in Dnase1-deficient mice. Nat Genet 25:177–181PubMedCrossRef Napirei M, Karsunky H, Zevnik B, Stephan H, Mannherz HG et al (2000) Features of systemic lupus erythematosus in Dnase1-deficient mice. Nat Genet 25:177–181PubMedCrossRef
12.
go back to reference Yasuda T, Nadano D, Iida R, Takeshita H, Lane SA et al (1995) Chromosomal assignment of the human deoxyribonuclease I gene, DNASE 1 (DNL1), to band 16p13.3 using the polymerase chain reaction. Cytogenet Cell Genet 70:221–223PubMedCrossRef Yasuda T, Nadano D, Iida R, Takeshita H, Lane SA et al (1995) Chromosomal assignment of the human deoxyribonuclease I gene, DNASE 1 (DNL1), to band 16p13.3 using the polymerase chain reaction. Cytogenet Cell Genet 70:221–223PubMedCrossRef
13.
go back to reference Yasuda T, Kishi K, Yanagawa Y, Yoshida A (1995) Structure of the human deoxyribonuclease I (DNase I) gene: identification of the nucleotide substitution that generates its classical genetic polymorphism. Ann Hum Genet 59:1–15PubMedCrossRef Yasuda T, Kishi K, Yanagawa Y, Yoshida A (1995) Structure of the human deoxyribonuclease I (DNase I) gene: identification of the nucleotide substitution that generates its classical genetic polymorphism. Ann Hum Genet 59:1–15PubMedCrossRef
14.
go back to reference Fujihara J, Takatsuka H, Kataoka K, Xue Y, Takeshita H (2007) Two deoxyribonuclease I gene polymorphisms and correlation between genotype and its activity in Japanese population. Leg Med (Tokyo) 9:233–236CrossRef Fujihara J, Takatsuka H, Kataoka K, Xue Y, Takeshita H (2007) Two deoxyribonuclease I gene polymorphisms and correlation between genotype and its activity in Japanese population. Leg Med (Tokyo) 9:233–236CrossRef
15.
go back to reference Yasutomo K, Horiuchi T, Kagami S, Tsukamoto H, Hashimura C et al (2001) Mutation of DNASE1 in people with systemic lupus erythematosus. Nat Genet 28:313–314PubMedCrossRef Yasutomo K, Horiuchi T, Kagami S, Tsukamoto H, Hashimura C et al (2001) Mutation of DNASE1 in people with systemic lupus erythematosus. Nat Genet 28:313–314PubMedCrossRef
16.
go back to reference AlFadhli S, AlTamimy B, Kharrat N, AlSaeid K, Haider MZ et al (2010) Molecular analysis of HumDN1 VNTR polymorphism of the human deoxyribonuclease I in systemic lupus erythematosus. Int J Immunogenet 37:5–8PubMedCrossRef AlFadhli S, AlTamimy B, Kharrat N, AlSaeid K, Haider MZ et al (2010) Molecular analysis of HumDN1 VNTR polymorphism of the human deoxyribonuclease I in systemic lupus erythematosus. Int J Immunogenet 37:5–8PubMedCrossRef
17.
go back to reference Tew MB, Johnson RW, Reveille JD, Tan FK (2001) A molecular analysis of the low serum deoxyribonuclease activity in lupus patients. Arthritis Rheum 44:2446–2447PubMedCrossRef Tew MB, Johnson RW, Reveille JD, Tan FK (2001) A molecular analysis of the low serum deoxyribonuclease activity in lupus patients. Arthritis Rheum 44:2446–2447PubMedCrossRef
18.
go back to reference Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725PubMedCrossRef Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725PubMedCrossRef
19.
go back to reference Mohammadoo-Khorasani M, Salimi S, Tabatabai E, Sandoughi M, Zakeri Z (2014) Association of interleukin-1 receptor antagonist gene 86bp VNTR polymorphism with systemic lupus erythematosus in South East of Iran. Zahedan J Res Med Sci 16(12):51–54 Mohammadoo-Khorasani M, Salimi S, Tabatabai E, Sandoughi M, Zakeri Z (2014) Association of interleukin-1 receptor antagonist gene 86bp VNTR polymorphism with systemic lupus erythematosus in South East of Iran. Zahedan J Res Med Sci 16(12):51–54
20.
go back to reference Narooie-Nejad M, Moossavi M, Torkamanzehi A, Moghtaderi A, Salimi S (2015) Vitamin D receptor gene polymorphism and the risk of multiple sclerosis in South Eastern of Iran. J Mol Neurosci 56(3):572–576PubMedCrossRef Narooie-Nejad M, Moossavi M, Torkamanzehi A, Moghtaderi A, Salimi S (2015) Vitamin D receptor gene polymorphism and the risk of multiple sclerosis in South Eastern of Iran. J Mol Neurosci 56(3):572–576PubMedCrossRef
21.
go back to reference Salimi S, Nakhaee A, Jafari M, Jahantigh D, Sandooghi M et al (2015) Combination effect of GSTM1, GSTT1 and GSTP1 polymorphisms and risk of systemic lupus erythematosus. Iran J Public Health 44:814PubMedPubMedCentral Salimi S, Nakhaee A, Jafari M, Jahantigh D, Sandooghi M et al (2015) Combination effect of GSTM1, GSTT1 and GSTP1 polymorphisms and risk of systemic lupus erythematosus. Iran J Public Health 44:814PubMedPubMedCentral
22.
go back to reference Narooie-Nejad M, Moossavi M, Torkamanzehi A, Moghtaderi A (2015) Positive association of vitamin D receptor gene variations with multiple sclerosis in South East Iranian Population. BioMed Res Int. doi:10.1155/2015/427519 Narooie-Nejad M, Moossavi M, Torkamanzehi A, Moghtaderi A (2015) Positive association of vitamin D receptor gene variations with multiple sclerosis in South East Iranian Population. BioMed Res Int. doi:10.​1155/​2015/​427519
23.
go back to reference Jahantigh D, Salimi S, Mousavi M, Moossavi M, Mohammadoo-Khorasani M et al (2015) Association between functional polymorphisms of DNA double-strand breaks in repair genes XRCC5, XRCC6 and XRCC7 with the risk of systemic lupus erythematosus in South East Iran. DNA Cell Biol 34:360–366PubMedCrossRef Jahantigh D, Salimi S, Mousavi M, Moossavi M, Mohammadoo-Khorasani M et al (2015) Association between functional polymorphisms of DNA double-strand breaks in repair genes XRCC5, XRCC6 and XRCC7 with the risk of systemic lupus erythematosus in South East Iran. DNA Cell Biol 34:360–366PubMedCrossRef
24.
go back to reference Shin HD, Park BL, Kim LH, Lee H-S, Kim T-Y et al (2004) Common DNase I polymorphism associated with autoantibody production among systemic lupus erythematosus patients. Hum Mol Genet 13:2343–2350PubMedCrossRef Shin HD, Park BL, Kim LH, Lee H-S, Kim T-Y et al (2004) Common DNase I polymorphism associated with autoantibody production among systemic lupus erythematosus patients. Hum Mol Genet 13:2343–2350PubMedCrossRef
25.
go back to reference AlFadhli S, Ghanem AA (2014) Influence of HumDN1 VNTR polymorphism on DNASE1 expression in systemic lupus erythematosus and rheumatoid arthritis. Immunol Investig 43(5):1–13CrossRef AlFadhli S, Ghanem AA (2014) Influence of HumDN1 VNTR polymorphism on DNASE1 expression in systemic lupus erythematosus and rheumatoid arthritis. Immunol Investig 43(5):1–13CrossRef
26.
go back to reference Frost P, Lachmann P (1968) The relationship of desoxyribonuclease inhibitor levels in human sera to the occurrence of antinuclear antibodies. Clin Exp Immunol 3:447PubMedPubMedCentral Frost P, Lachmann P (1968) The relationship of desoxyribonuclease inhibitor levels in human sera to the occurrence of antinuclear antibodies. Clin Exp Immunol 3:447PubMedPubMedCentral
27.
go back to reference Chitrabamrung S, Rubin R, Tan E (1981) Serum deoxyribonuclease I and clinical activity in systemic lupus erythematosus. Rheumatol Int 1:55–60PubMedCrossRef Chitrabamrung S, Rubin R, Tan E (1981) Serum deoxyribonuclease I and clinical activity in systemic lupus erythematosus. Rheumatol Int 1:55–60PubMedCrossRef
28.
go back to reference Napirei M, Karsunky H, Zevnik B, Stephan H, Möröy T (2000) Features of systemic lupus erythematosus in Dnase1-deficient mice. Nat Genet 25:177–181PubMedCrossRef Napirei M, Karsunky H, Zevnik B, Stephan H, Möröy T (2000) Features of systemic lupus erythematosus in Dnase1-deficient mice. Nat Genet 25:177–181PubMedCrossRef
29.
go back to reference Fujihara J, Yasuda T, Shiwaku K, Takeshita H (2006) Frequency of a single nucleotide (A2317G) and 56-bp variable number of tandem repeat polymorphisms within the deoxyribonuclease I gene in five ethnic populations. Clin Chem Lab Med 44:1188–1191PubMedCrossRef Fujihara J, Yasuda T, Shiwaku K, Takeshita H (2006) Frequency of a single nucleotide (A2317G) and 56-bp variable number of tandem repeat polymorphisms within the deoxyribonuclease I gene in five ethnic populations. Clin Chem Lab Med 44:1188–1191PubMedCrossRef
30.
go back to reference Fujihara J, Takatsuka H, Kataoka K, Xue Y, Takeshita H (2007) Two deoxyribonuclease I gene polymorphisms and correlation between genotype and its activity in Japanese population. Leg Med 9:233–236CrossRef Fujihara J, Takatsuka H, Kataoka K, Xue Y, Takeshita H (2007) Two deoxyribonuclease I gene polymorphisms and correlation between genotype and its activity in Japanese population. Leg Med 9:233–236CrossRef
31.
go back to reference Yasuda T, Iida R, Ueki M, Tsukahara T, Nakajima T et al (2004) A novel 56-bp variable tandem repeat polymorphism in the human deoxyribonuclease I gene and its population data. Leg Med (Tokyo) 6:242–245CrossRef Yasuda T, Iida R, Ueki M, Tsukahara T, Nakajima T et al (2004) A novel 56-bp variable tandem repeat polymorphism in the human deoxyribonuclease I gene and its population data. Leg Med (Tokyo) 6:242–245CrossRef
Metadata
Title
Deoxyribonuclease I gene polymorphism and susceptibility to systemic lupus erythematosus
Authors
Milad Mohammadoo-Khorasani
Mahsa Musavi
Mahdieh Mousavi
Maryam Moossavi
Maryam Khoddamian
Mahnaz Sandoughi
Zahra Zakeri
Publication date
01-01-2016
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 1/2016
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-015-3111-y

Other articles of this Issue 1/2016

Clinical Rheumatology 1/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine